# Leonard A. Potter

> Leonard A. Potter is a Series A investor at Infinity Q Capital Management, LLC backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug…

- Type: Angel Investor
- Fund: [Infinity Q Capital Management, LLC](https://shizune.co/investors/profile/infinity-q-capital-management-llc)
- Location: New York, United States
- Total investments: 2
- Last investment: May 2018
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/len-potter-55985313

Leonard A. Potter is a Series A investor at Infinity Q Capital Management, LLC in New York focused on Biotechnology and Health Diagnostics. Mr. Potter has served as a member of our Board of Directors since 2011. Mr. Potter is currently the President and Chief Investment Officer of Wildcat Capital Management, LLC, a registered investment advisor. From August 2009 through August 2011, Mr. Potter served as the Chief Investment Officer of Salt Creek Hospitality, a private acquirer andowner of hospitality related assets. From December 2002 through July 2009, Mr. Potter was a Managing Director — Soros Private Equity at Soros Fund Management LLC (“SFM”) where, from May 2005 through July 2009, Mr. Potter served as co-head of the Private Equity group and a member of the Private Equity Investment Committee. From September 1998 until joining SFM in 2002, Mr. Potter was a Managing Director of Alpine Consolidated LLC, a private merchant bank, and from April 1996 through September 1998, Mr. Potter founded and served as a Managing Director of Capstone Partners LLC, a private merchant bank. Prior to founding Capstone Partners, Mr. Potter was an attorney specializing in mergers, acquisitions and corporate finance at Morgan, Lewis & Bockius and Willkie Farr & Gallagher. Mr. Potter is currently a member of the board of directors of Solar Senior Capital, Ltd., Solar Capital Ltd. and GSV Capital, each a business development company, and Crumbs Bake Shop, Inc. (“CRMB”), and has previously served as a board member of several other public companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Health Diagnostics | 2 | 100% |
| Health Care | 1 | 50% |
| Neuroscience | 1 | 50% |
| Pharmaceutical | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuroVision Imaging | NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trialsglobally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases. | $11.2M | Series C | May 02, 2018 |  |
| NeuroVision Imaging | NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trialsglobally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases. | $10M | Series B | Jun 29, 2016 |  |

2 of 2 investments shown.

## Co-investors
- [Johnson & Johnson Innovation](https://shizune.co/investors/profile/johnson-johnson-innovation-jjdc) — VC Fund, 1 deal together
- [Wildcat Capital Management](https://shizune.co/investors/profile/wildcat-capital-management) — VC Fund, 1 deal together

## About Infinity Q Capital Management, LLC

VC Fund · New York, United States

Infinity Q Capital Management is a pioneering investment advisor managed by David Bonderman’s family office.

2 contacts available at Infinity Q Capital Management, LLC.

| Name | Title | Profile |
| --- | --- | --- |
| Leonard A. Potter | Non Executive Director | https://shizune.co/investors/profile/leonard-potter |
| Leonard A. Potter | Non Executive Director | https://shizune.co/investors/profile/leonard-a-potter |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Leonard A. Potter invest in?

Leonard A. Potter invests primarily in Biotechnology, Health Diagnostics and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Leonard A. Potter last invest?

The most recent investment recorded for Leonard A. Potter closed in May 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co